Session 2 Q&A Session with Panel

Speakers

• WS

  William (Billy) C. Smith

  Research Scientist, DPQR V, OPQR, OPQ, CDER · FDA

  Moderator

• JA

  Jankiben Andhariya

  Senior Scientific Reviewer, DB II, OB, OGD · FDA

  Panelist

• DB

  Diane J. Burgess

  Distinguished Professor of Pharmaceutics, Pfizer Distinguished Endowed Chair in Pharmaceutical Technology · University of Connecticut

  Panelist

• AC

  Andrew Clark

  Senior Director, Research and Strategy · digiM Solution LLC

  Panelist

• CJ

  Coleman Johnson

  Postdoctoral Research Fellow, OPQR, OPQ, CDER · FDA

  Panelist

• AK

  Ajay J. Khopade

  Vice President & Head, Formulation Development (Non-Orals) · Sun Pharmaceutical Industries Limited R&D

  Panelist

• NM

  Naresh Mittapelly

  Senior Research Scientist, Mechanistic Modelling & Simulation · Certara Predictive Technologies (Simcyp Division)

  Panelist

• HQ

  Haiou Qu

  Staff Fellow, OPQR, OPQ, CDER · FDA

  Panelist

• DS

  Dinesh Satone

  General Manager · Orbicular Pharmaceutical Technologies Ltd.

  Panelist

• JS

  Jaymin Shah

  Senior Research Fellow and Global Head of Biopharmaceutics, Pharmaceutical Sciences Small Molecules · Pfizer

  Panelist

• FZ

  Feng Zhang

  Associate Professor, Molecular Pharmaceutics & Drug Delivery, College of Pharmacy · The University of Texas at Austin

  Panelist